GoodRx Holdings (GDRX) | Financial Analysis & Statements

GoodRx Holdings Inc. | Small-cap | Healthcare

$4.71

-6.82%

GoodRx Holdings vs Veeva Systems GoodRx Holdings vs Ge Healthcare GoodRx Holdings vs Premier GoodRx Holdings vs Certara GoodRx Holdings vs Schrodinger GoodRx Holdings vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 792.3M

Gross Profit 744.1M 93.91%

Operating Income 65.8M 8.31%

Net Income 16.4M 2.07%

EPS (Diluted) $0.04

Balance Sheet Metrics

Total Assets 1.4B

Total Liabilities 663.4M

Shareholders Equity 724.7M

Debt to Equity 0.92

Cash Flow Metrics

Operating Cash Flow 149.8M

Free Cash Flow 113.5M

Revenue & Profitability Trend

GoodRx Holdings Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	792.3M	750.3M	766.6M	745.4M	550.7M
Cost of Goods Sold	48.2M	66.9M	65.1M	46.7M	29.6M
Gross Profit	744.1M	683.3M	701.5M	698.7M	521.1M
Operating Expenses	608.7M	602.7M	645.6M	650.8M	778.4M
Operating Income	65.8M	-27.0M	1.7M	13.4M	-275.7M
Pre-tax Income	31.5M	-55.6M	-23.2M	-10.2M	-303.4M
Income Tax	15.1M	-46.7M	9.6M	15.1M	-9.8M
Net Income	16.4M	-8.9M	-32.8M	-25.3M	-293.6M
EPS (Diluted)	$0.04	-$0.02	-$0.08	-$0.06	-$1.07

Income Statement Trend

GoodRx Holdings Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	659.3M	872.8M	919.7M	1.1B	1.1B
Non-Current Assets	728.8M	716.0M	684.9M	518.8M	383.7M
Total Assets	1.4B	1.6B	1.6B	1.6B	1.5B
Liabilities
Current Liabilities	123.9M	122.6M	76.3M	81.1M	59.6M
Non-Current Liabilities	539.5M	704.3M	713.5M	694.8M	699.2M
Total Liabilities	663.4M	826.8M	789.8M	775.9M	758.8M
Equity
Total Shareholders Equity	724.7M	762.0M	814.8M	831.7M	711.4M

Balance Sheet Composition

GoodRx Holdings Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	16.4M	-8.9M	-32.8M	-25.3M	-293.6M
Operating Cash Flow	149.8M	139.9M	164.5M	146.3M	159.2M
Investing Activities
Capital Expenditures	-1.2M	-1.0M	-4.0M	-4.6M	-20.6M
Investing Cash Flow	-1.2M	-1.0M	-159.3M	-148.8M	-76.3M
Financing Activities
Dividends Paid	-	-	-	-	0
Financing Cash Flow	-358.3M	-174.7M	-129.4M	-65.5M	899.8M
Free Cash Flow	113.5M	82.5M	91.6M	144.3M	95.5M

Cash Flow Trend

GoodRx Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 67.00

Forward P/E 11.44

Price to Book 2.59

Price to Sales 2.10

PEG Ratio 11.44

Profitability Ratios

Profit Margin 3.57%

Operating Margin 13.69%

Return on Equity 4.43%

Return on Assets 4.26%

Financial Health

Current Ratio 5.22

Debt to Equity 82.71

Beta 1.17

Per Share Data

EPS (TTM) $0.07

Book Value per Share $1.81

Revenue per Share $2.08

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
gdrx	1.7B	67.00	2.59	4.43%	3.57%	82.71
Veeva Systems	46.0B	59.92	7.39	14.06%	27.34%	1.24
Ge Healthcare	32.6B	14.95	3.55	26.44%	11.03%	97.52
Premier	1.9B	21.46	1.18	6.85%	4.96%	19.35
Certara	1.7B	104.00	1.56	-0.25%	-0.67%	28.51
Schrodinger	1.5B	44.39	4.05	-43.33%	-83.39%	31.15

Financial data is updated regularly. All figures are in the company's reporting currency.